syk/wmgi revisit deal
debt deal done revisit wright deal strateg
rational unchang updat deal model conclud
less dilut still low higher leverag could come
opportun cost execut recon
recoveri shoulder robot keep us construct
syk/wmgi pend acquisit wright
medic met mix emot investor under-perform
 point one hand strategi consist
 philosophi establish categori leadership
convers repres largest acquisit dollar term near-
term dilut appear underwhelm return sinc
announc novemb gross arb spread volatil reach
wide mid-march low sinc narrow
market recov wright sharehold approv merger
manag reiter tent close earn call
admittedli much transpir sinc deal announc novemb
given unpreced impact recent debt price
take opportun revisit deal model
reflect impact wright financi recal new normal note
appli seri framework bottom-up analysi adjust
model refin follow result dilig
corpor commentari origin wright medic estim
reflect therefor adjust estim appli similar
framework use across coverag revenu came
normal forecast normal given extrem procedur
gener highli elective/deferr margin larger proport
extrem procedur skew asc/outpati set mainli
foot/ankl expect rapid recoveri inpati procedur
see net model revenu level
expect revenu normal consist ortho peer
coverag direct updat estim reflect
prior deal model caution may addit disrupt result
dis-synergi like obfusc pleas see exhibit
regulatori updat outsid disclos anticip close timelin
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
manag notabl vagu respect comment anti-trust
potenti divestitur base close timelin dilut math
industri experi believ potenti divestitur like although
offici announc date variou news sourc
dealreport mlex report combin entiti contempl
divest ankl busi toe joint product and/or finger implant
product help overcom ftc anti-trust concern merger file legal
disclosur state remedi shall limit total ankl replac
product servic product servic repres
individu aggreg less annual revenu
gener fiscal year therefor assum ankl combin
product may divest factor divestitur
placehold origin deal model state like exce
size total ankl busi divest product could
closer given outcom unknown rel
conservat leav divestitur assumpt unchang
divestitur closer annual revenu could drive bp
vs model key catalyst watch area includ
uk phase decis juli us hsr
state major transact would financ new debt
estim origin deal model assum interest rate
similar exist outstand debt decemb compani rais
eur debt weight averag rate well forecast
flag potenti pocket conservat deal
model given remain debt would need rais rate equal
overal see like expect rais
remain three tranch debt week weighted-averag rate
net newli issu debt rais weighted-
averag interest rate drive ep rel origin deal
still defens strateg rational remain consist
long-term strategi reach categori leadership recent commentari
ceo kevin lobo earn call signal commit deal
clear execut risk gone result impact
elect extrem busi reflect chang new
deal model see exhibit conclus polar
transact appear less dilut ep perspect vs
manag prior estim primarili result favor
debt term compon drive chang includ covid-
impact oper forecast debt financ
investor sensit near-term dilut result
on-going debat share
vs prior financi return still
underwhelm see effect becom lost
year due ad anoth year model
arriv similar year wright transform
ask investor take long-term view relat
balanc sheet appear strain net leverag
coven concern address histor elev
level leverag may lead opportun cost pursu near-term
 larg cap peer may becom activ
robot critic compon recon corpor growth
strategi mako specif next joint
believ shoulder ahead spine even recent mobiu
transact recent manag commentari suggest shoulder
applic progress well could key focu area
expect greater specif launch time robot shoulder
applic could import sentiment driver stock post-
merger perhap play role retent
phase recoveri trade within phase recoveri model classifi stryker
phase recoveri asset given non-emerg procedur exposur ortho
spine exposur capit therefor gener assum slower
intermediate-term recoveri state phase note earlier week
see phase stock show sign recoveri sever dynam
worth consider
state previous recon recoveri may lag broader
implant devic recoveri hospit open see
concern econom sensit notwithstand analysi
proven signific correl recon unemploy
see
oper perform reproach
fact take comfort uncertain environ
outlay financ
gener transact net incom contribut
net chang less interest debt
ep impact
acquir sale
acquir cost
pf divestitur
valuat methodolog risk
deriv base case scenario multipl two-turn premium larg cap
peer see warrant given durabl premium growth profil
howev modestli larg cap growth peer given leverag ep growth
limit rel
risk upsid
favor mix continu mako cementless knee
risk downsid
ortho recon procedur remain significantli impact
organ growth deceler y/i closer wamgr
wright medic dis-synergi dilut greater forecast
competit environ ortho robot worsen
